Talaris Therapeutics IncTalaris Therapeutics Inc - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

This ESG score for Talaris Therapeutics Inc indicates its transparency towards the UN SDGs. This article contains a questions and answers section about Talaris Therapeutics Inc. This assessment of Talaris Therapeutics Inc is assembled by All Street Sevva using proprietary AI.

Talaris Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.4; made up of an environmental score of 2.0, social score of 6.4 and governance score of 4.8.

SDG Transparency Score for Talaris Therapeutics Inc 
Low
0 - 3

4.4

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2024-05-01
What drives the score for Talaris Therapeutics Inc 
2.0

Environmental

6.4

Social

4.8

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Caladrius Biosciences Inc
8.0
High
1Can Fite Biopharma Ltd
8.0
High
868Trevena Inc
4.5
High
868Urogen Pharma Ltd
4.5
High
910Talaris Therapeutics Inc
4.4
High
910CanBas Co Ltd
4.4
High
910CNS Pharmaceuticals Inc
4.4
High
.........
1970Zyden Gentec Ltd
0.0
Low
1970iNtRON Biotechnology Inc
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Talaris Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Talaris Therapeutics Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Talaris Therapeutics Inc report the average age of the workforce?

LockedSign up for free to unlock

Does Talaris Therapeutics Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Talaris Therapeutics Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Talaris Therapeutics Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does Talaris Therapeutics Inc offer flexible work?

LockedSign up for free to unlock

Does Talaris Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Talaris Therapeutics Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Talaris Therapeutics Inc conduct supply chain audits?

LockedSign up for free to unlock

Does Talaris Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Talaris Therapeutics Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Talaris Therapeutics Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Talaris Therapeutics Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Talaris Therapeutics Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Talaris Therapeutics Inc disclose water use targets?

LockedSign up for free to unlock

Does Talaris Therapeutics Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Talaris Therapeutics Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does Talaris Therapeutics Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does Talaris Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Talaris Therapeutics Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Talaris Therapeutics Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does Talaris Therapeutics Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Talaris Therapeutics Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Talaris Therapeutics Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Talaris Therapeutics Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Talaris Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Talaris Therapeutics Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Talaris Therapeutics Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Talaris Therapeutics Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Talaris Therapeutics Inc disclose its waste policy?

LockedSign up for free to unlock

Does Talaris Therapeutics Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does Talaris Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Talaris Therapeutics Inc disclose energy use targets?

LockedSign up for free to unlock

Does Talaris Therapeutics Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Talaris Therapeutics Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Talaris Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.

Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, and metabolic disorders. Its lead product candidate is FCR001, a novel allogeneic cell therapy that is in Phase II trial for living donor kidney transplant patients. The company is also developing FCR002 in deceased donor kidney transplants; FCR001 in patients with a severe form of scleroderma; and FCR001 for one or more severe non-malignant blood, immune, or metabolic disorders. Talaris Therapeutics, Inc. was founded in 1988 and is headquartered in Louisville, Kentucky.

Sorry!

Failed to process!